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Background:  The  whole  body  periodic  acceleration  (WBPA)  system  was  recently  developed  as  a passive
exercise  device  by  providing  increased  pulsatile  shear  stress  for  improvement  of  endothelial  function.
This  study  aimed  to  investigate  the acute  effects  of  WBPA  on  coronary  microcirculation  and  glucose
tolerance  in patients  with  type  2 diabetes  (T2D).
Methods: The  study  subjects  were  8 patients  with  T2D  who  underwent  transthoracic  Doppler  echocar-
diography  for the  assessment  of  coronary  ﬂow  reserve  (CFR)  before  and  immediately  after  a 45-min
session  of WBPA.  The  ﬂow  velocity  in the  distal  portion  of  the  left  anterior  descending  coronary  artery
was measured  at baseline  and  during  adenosine  infusion.  The  CFR  represented  the ratio  of  hyperemic  to
basal  mean  diastolic  ﬂow  velocity.xercise Results:  WBPA  increased  CFR  from  2.3  ±  0.3  to 2.6  ±  0.4  (p = 0.02).  WBPA  decreased  serum  insulin  level
from  26  ±  19 IU/ml  to 19 ± 15  IU/ml  (p =  0.01)  and  increased  total  adiponectin  from  11.6  ±  7.3 g/ml  to
12.5  ± 8.0 g/ml (p =  0.02)  and  high  molecular  weight  adiponectin  from  4.9  ±  3.6 g/ml  to 5.3  ± 3.9  g/ml
(p  =  0.03),  whereas  the  serum  glucose  level  was stable  from  207  ±  66  mg/dl  to  203 ±  56  mg/dl  (p  = 0.8).
Conclusions:  This  study  demonstrates  that  a single  session  of  WBPA  treatment  simultaneously  improved
coronary  microcirculation  and  glucose  tolerance  in patients  with  T2D.
2  Jap©  201
ntroduction
Exercise has been considered a cornerstone in the management
f type 2 diabetes (T2D), along with diet and medications [1–4].
atients with diabetes are advised to engage in regular moderate
erobic exercise for at least 30 min  a day for at least ﬁve days a
eek [5]. One of the physiological changes responsible for health
nd cardio-metabolic beneﬁts of exercise is mediated by chang-
ng the secretion of adipokines. Increased circulating adiponectin
∗ Corresponding author at: Department of Medicine, Osaka Ekisaikai Hospital, 2-
-10 Honden, Nishi-ku, Osaka 550-0022, Japan. Tel.: +81 6 6581 2881;
ax: +81 6 6584 1807.
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[6–8], particularly high molecular weight adiponectin [9,10],  plays
an important role in T2D due to its insulin sensitizing [6],  anti-
inﬂammatory [7],  and anti-atherogenic properties [8].  However,
care is sometimes needed in exercising T2D patients with compli-
cations [11]. Furthermore, the recommended intensity of exercise
might not be achievable in patients with concomitant neurolog-
ical and rheumatological diseases, mobility problems, and frailty
among others.
Whole body periodic acceleration (WBPA) serves as an alter-
native or complement to active exercise because it increases
shear stress to the endothelium [12]. This form of passive exer-
cise increases the pulsatile shear stress to the endothelium and
endomyocardium to increase the release of nitric oxide due to
the stimulation of endothelial nitric oxide synthase (eNOS), up-
regulation of eNOS, and improvement in peripheral endothelial
vier Ltd. All rights reserved.
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cig. 1. Transthoracic Doppler echocardiography images demonstrating the techniqu
rtery.  (A) Visualization of coronary blood ﬂow in the distal LAD. (B) Measurement 
unction [13–15].  Our reports showed that WBPA improved coro-
ary microcirculation [16] and peripheral endothelial function [17],
hich was recently supported by experimental study [18], how-
ver, there are no studies on the effects of WBPA on glucose
olerance in humans. The present study was designed to investi-
ate the acute effects of passive exercise with WBPA on coronary
icrocirculation as well as on glucose tolerance in patients with
2D. Coronary ﬂow reserve (CFR) was measured by transthoracic
oppler echocardiography (TTDE) to assess the status of coronary
icrocirculation.
ethods
tudy population
The study was approved by the Institutional Review Board of
he Osaka Ekisaikai Hospital. The study subjects were 8 consec-
tive patients (8 men, 69 ± 7 years) with T2D for more than 1
ear. All patients were referred for coronary angiography to eval-
ate coronary artery disease. We  excluded patients with history of
yocardial infarction, left ventricular ejection fraction of less than
0%, valvular heart disease, and dilated or hypertrophic cardiomy-
pathy. Patients had TTDE examination before and immediately
fter a session of WBPA treatment. All patients were asked to
bstain from smoking and alcohol for 24 h before the study. WBPA
reatment was done after >3 h of fasting. Blood samples were taken
t each TTDE examination to determine plasma glucose, insulin,
otal adiponectin, and high molecular weight adiponectin, as pre-
iously described [19,20].  Eight patients with T2D (8 men, 69 ± 7
ears) also served as an age- and gender-matched control group
n order to investigate the effect of 45-min rest without WBPA
reatment on glucose tolerance.
hole body periodic acceleration
WBPA was applied using the AT-101 (Non-Invasive Monitoring
ystems, Inc., Miami, FL, USA), a device that consists of a motion
latform with a gurney-like appearance, driven by a two-ﬂywheel
otor assembly [16–18].  The device measures 222 cm in length,
7.5 cm in width, and 211 kg in weight. A hand-held controller
llows the operator to start and stop as well as regulate the speed
nd acceleration of the device. With the subjects laying supine on a
attress placed on the motion platform, repetitive head-to-foot
ovements delivered at approximately 140 cycles/min and g of
2.2 m/s2 for 45 min. A foot board strapped the patient’s feet to
ouple the body to the motion platform during the session.easurement of coronary ﬂow reserve in the left anterior descending (LAD) coronary
al mean diastolic ﬂow velocity. (C) Measurement of hyperemic ﬂow velocity.
CFR measurement by TTDE
CFR was measured before and immediately after the 45 min
WBPA session. For measurement of CFR, TTDE was performed with
the Sequoia 512 instrument (Siemens Medical Solutions, Moun-
tainview, CA, USA). The ﬂow in the distal portion of the left anterior
descending (LAD) coronary artery was explored with a modiﬁed
foreshortened 2-chamber view. The acoustic window was around
the mid-clavicular line in the fourth and ﬁfth intercostal spaces
with patients in the left lateral decubitus position, and the ultra-
sound beam was inclined laterally. Under the guidance of color ﬂow
mapping, the coronary blood ﬂow in the distal LAD was identi-
ﬁed as a color-ﬁlled tubular structure in the anterior groove area
(Fig. 1A). The long-axis sections were carefully adjusted to mini-
mize the angle between the Doppler beam and the LAD ﬂow. Angle
correction was performed if the angle between color ﬂow and the
Doppler beam was  >20%. The coronary blood ﬂow velocity was
measured at baseline and after intravenous infusion of adenosine
triphosphate (ATP) at a rate of 0.14 mg/kg/min for 2 min to pro-
duce hyperemia (Fig. 1B and C). The mean diastolic ﬂow velocity
was measured by tracing the contour of the spectral Doppler sig-
nal. The ratio of hyperemic to basal mean diastolic ﬂow velocity
was calculated as CFR. The values of 3 cycles were averaged for
each variable in the CFR measurements. TTDE examinations were
conducted by an expert sonographer with >5 years experience in
echocardiography and approximately 100 CFR examinations. They
were blinded to other clinical information.
Coronary angiography
Coronary angiography was performed using the standard
Judkins technique. Multiple projections were used to evaluate coro-
nary narrowing by one investigator who  was  blinded to the clinical
data. The severity of coronary narrowing was visually estimated
by comparison of the luminal diameter of the segment exhibiting
narrowing to the luminal diameter of the most normal-appearing
site immediately proximal to the narrowing. Signiﬁcant coronary
narrowing was  deﬁned if there was  ≥50% diameter narrowing on
coronary angiography.
Statistical analysis
Values were expressed as mean ± SD. Laboratory and echocar-
diographic data before and after WBPA were compared by the
paired t test. Clinical characteristics between patients with WBPA
treatment and controls were compared with chi-square statistic
for categorical variables or by unpaired t test for continuous vari-
ables. Two-way repeated measures analysis of variance, testing for
WBPA effect, ATP effect, and their interaction was used to evaluate
M. Sakaguchi et al. / Journal of Cardiology 60 (2012) 283–287 285
Table  1
Patients’ characteristics.
WBPA group Control group p-Value
Height, cm 164 ± 6 166 ± 10 0.6
Weight, kg 63 ± 8 63 ± 9 0.9
Body  mass index, kg/m2 23.5 ± 1.8 23.0 ± 2.6 0.6
Waist circumference, cm 85 ± 6 82 ± 9 0.4
Risk  factor
Hypertension, n (%) 7 (88) 6 (75) 0.5
Hypercholesterolemia, n (%) 4 (50) 3 (38) 0.6
Smoking, n (%) 3 (38) 3 (38) –
History of stroke, n (%) 3 (38) 2 (25) 0.6
History of peripheral arterial disease, n (%) 1 (13) 1 (13) –
Years since diagnosis, years 8.0 ± 5.2 7.8 ± 5.6 0.9
Coronary angiography (≥50% stenosis)
Right coronary artery, n (%) 2 (25)
LAD, n (%) 5 (63)
Left  circumﬂex coronary artery, n (%) 5 (63)
Ejection fraction, % 59 ± 5 52 ± 10 0.1
Cardiac medications
Diuretic, n (%) 0 (0) 2 (25) 0.1
Beta-blockers, n (%) 0 (0) 2 (25) 0.1
Calcium channel blockers, n (%) 5 (63) 2 (25) 0.1
ACE  inhibitors or ARB, n (%) 6 (75) 4 (50) 0.3
Statin, n (%) 5 (63) 3 (38) 0.3
Antiplatelet agent, n (%) 8 (100) 6 (75) 0.1
Medications for diabetes
Diet alone 0 (0) 0 (0) –
Oral  hypoglycemic agent 6 (75) 7 (88) 0.5
Insulin 2 (25) 1 (13) 0.5
Hemoglobin A1c, % 7.5 ± 1.2 8.2 ± 2.0 0.4
Serum creatinine, mg/dl 1.11 ± 0.28 0.97 ± 0.34 0.4
eGFR,  ml  min−1 1.73 m−2 55 ± 17 65 ± 18 0.3
D n-converting enzyme; ARB, angiotensin receptor blockers; eGFR, estimated glomerular
ﬁ y periodic acceleration.
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Table 2
Hemodynamics and echocardiographic results before and after WBPA.
Before WBPA After WBPA p-Value
Heart rate, beats/min
Baseline 66 ± 12 66 ± 9 0.7
ATP  infusion 67 ± 12 68 ± 10
Systolic blood pressure, mmHg
Baseline 127 ± 19 141 ± 27 0.4
ATP infusion 130 ± 25 137 ± 25
Mean diastolic ﬂow velocity, cm/s
Baseline 22 ± 12 21 ± 7 0.1
ATP  infusion 51 ± 26* 56 ± 24*
The column showed p-values for the interaction of WBPA and ATP effects, testingata are presented as mean value ± SD or number (%) of patients. ACE, angiotensi
ltration rate; LAD, left anterior descending coronary artery; and WBPA, whole bod
eart rate, blood pressure, and mean diastolic ﬂow velocity after
TP infusion in pre- and post-WBPA. Differences were considered
igniﬁcant at p < 0.05.
esults
Table 1 lists the clinical characteristics of the study partici-
ants with T2D in WBPA group and control group, respectively. All
atients had signiﬁcant coronary narrowing on angiography. WBPA
ere completed and well-tolerated in all patients, and no signif-
cant hemodynamic or mechanical complications were observed
uring the procedure or follow-up.
Analysis of data of all 8 patients demonstrated that CFR
ncreased from 2.3 ± 0.3 at baseline to 2.6 ± 0.4 after a single 45-
in  session of WBPA (p = 0.02) (Fig. 2). Table 2 shows the values of
ig. 2. Effect of whole body periodic acceleration (WBPA) on coronary ﬂow reserve
CFR) in patients with (open square) and without (closed square) a left anterior
escending artery (LAD) narrowing.from two-way repeated measures ANOVA.
* p < 0.05 vs the corresponding parameter before ATP infusion. ATP, adenosine
triphosphate and WBPA, whole body periodic acceleration.hemodynamics and mean diastolic ﬂow velocity before and after
WBPA at rest and during ATP infusion. Two-way ANOVA showed
no signiﬁcant interactions in terms of heart rate, systolic blood
pressure, and mean diastolic ﬂow velocity.
Table 3
Laboratory data before and after WBPA.
Before WBPA After WBPA p-Value
White blood cell, /mm3 5926 ± 1146 4950 ± 2239 0.1
Hematocrit, % 35.3 ± 3.9 36.2 ± 3.3 0.09
High-sensitive CRP, mg/dl 0.85 ± 1.63 0.93 ± 1.77 0.1
Glucose, mg/dl 207 ± 66 203 ± 56 0.8
Serum insulin, IU/ml 26 ± 19 19 ± 15 0.01
Total adiponectin, g/ml 11.6 ± 7.3 12.5 ± 8.0 0.02
High molecular weight
adiponectin, g/ml
4.9 ± 3.6 5.3 ± 3.9 0.03
Urinary albumin, g/g Cr 380 ± 850 358 ± 653 0.3
Cr, serum creatinine; CRP, C-reactive protein; and WBPA, whole body periodic accel-
eration.
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Table 3 demonstrates the laboratory data before and after
BPA. WBPA resulted in a decrease in serum insulin con-
entration (26 ± 19 IU/ml to 19 ± 15 IU/ml, p = 0.01), had no
igniﬁcant effect on blood glucose level (207 ± 66 mg/dl to
03 ± 56 mg/dl, p = 0.8). In 6 patients who received oral hypo-
lycemic agents, serum insulin concentration decreased from
8 ± 22 IU/ml to 20 ± 18 IU/ml (p = 0.02), whereas blood glucose
evel was stable (214 ± 69 mg/dl to 204 ± 62 mg/dl, p = 0.6). Total
11.6 ± 7.3 g/ml to 12.5 ± 8.0 g/ml, p = 0.02) and high molecu-
ar weight adiponectins (4.9 ± 3.6 g/ml to 5.3 ± 3.9 g/ml, p = 0.03)
ncreased after the treatment, respectively. WBPA had no effect on
ther parameters.
In the control study, 45 min  of rest without WBPA treatment
id not alter the serum glucose (185 ± 68 mg/dl to 177 ± 66 mg/dl,
 = 0.4) and insulin levels (18 ± 17 IU/ml to 18 ± 14 IU/ml,
 = 0.7), respectively.
iscussion
revious observations of WBPA
Exercise training increases vascular shear stress of the
eripheral and coronary endothelia, leading to a reduction in car-
iovascular morbidity and mortality [1,2,5].  However, attention
s needed when exercising patients with certain T2D complica-
ions, such as those with severe retinopathy (who are at risk of
emorrhage or retinal detachment), with nephropathy (at risk of
roteinuria due to acute rise in blood pressure), and those with
europathy (at risk of postural hypotension or skin infection) [11].
t is therefore important to devise alternative physical activities
f moderate intensity in such T2D patients who cannot exercise
t a sufﬁcient level. Passive exercise refers to exercise performed
ithout volitional control and is a potential alternative and com-
lementary to active exercise. The efﬁcacy of passive exercise as
n exercise per se is, however, questionable because it does not
mprove hemodynamics as does active exercise [21–23].
WBPA repetitively moves the horizontally positioned body head
o foot in the direction of the spinal axis. It causes inertial shifts
f blood as the motion platform accelerates and decelerates to
dd pulses to the circulation thereby increasing shear stress to the
ndothelium [12]. This is one of the important beneﬁts of exercise
raining because increased shear stress produces enhanced release
f nitric oxide from the endothelium and endomyocardium through
he activation and up-regulation of eNOS [13–15].  Our recent clini-
al [17] and experimental [18] investigations strongly suggest that
BPA results in improvement of endothelial function in peripheral
rteries. Another study showed that CFR in response to adeno-
ine increased after WBPA in patients with and without coronary
rtery narrowing [16]. Although adenosine is a vasodilator mainly
n an endothelium-independent manner by rapidly increasing the
ocal concentration of adenosine, adenosine’s vasodilatory effect
epends at least partly on coronary endothelial function [24–26].  To
ur knowledge, however, there are no data on whether the WBPA-
nduced modiﬁcation of the blood ﬂow in coronary and peripheral
rteries and/or systemic conditions improves glucose tolerance.
BPA on adiponectin and glucose tolerance
In the present study, we demonstrated that a single session
f WBPA treatment decreases serum insulin concentration, main-
aining the same level of blood glucose. This indicates that WBPA
mproves glucose tolerance. Correspondingly, total and high molec-
lar weight adiponectins, which act as a key modulator of insulin
ensitivity and glucose metabolism [6–10], increase after WBPA
reatment. However, the acute effect of exercise on circulatingdiology 60 (2012) 283–287
adiponectin concentration is varied in the clinical setting [27,28],
depending on study population and the intensity/duration of exer-
cise. The result of the present study suggests that shear stress to
the endothelium, one of the important beneﬁcial effects of exercise,
plays a central role in increasing circulating adiponectin after exer-
cise in patients with advanced atherosclerosis. All patients included
in our study had T2D for more than 1 year and concomitant coro-
nary artery disease. Consequently, this study supports the use of
WBPA in patients with T2D for improving the status of coronary
microcirculation and glucose tolerance, especially in patients who
are incapable or unwilling to exercise at a sufﬁcient level.
Study limitations
Several limitations should be mentioned. The number of
patients was small (n = 8). The degree of CFR improvement after
WBPA treatment tended to be larger in patients without LAD nar-
rowing than those with LAD narrowing (27.0 ± 16.0% vs 6.3 ± 3.6%).
However, statistical analysis was not examined in this sub-analysis
due to the small number of patients and inadequate statisti-
cal power. Future investigations with a large number of patients
might be necessary to clarify the determinant of the degree of CFR
improvement after WBPA treatment as well as to investigate the
detailed mechanisms of WBPA treatment on the modiﬁcations of
coronary microcirculation and adiponectin. In addition, the long-
term outcome remains unknown. Furthermore, we investigated the
effect of only a single 45-min session of WBPA. Repeated sessions
of WBPA would strengthen the effect of WBPA, as we previously
reported [18].
Most patients continued taking one or more medications during
examinations, including angiotensin-converting enzyme inhibitors
(75%), statins (63%), and thiazolidinedione (25%). Such medications
and the degree of daily physical activity in individuals might affect
the results of CFR. Also, WBPA treatment was  done after >3 h of fas-
ting. Also, glucose tolerance was unchanged in the control group.
However, considering that most patients were treated with oral
hypoglycemic agents, this time interval between latest fasting and
WBPA treatment might not be enough to evaluate glucose toler-
ance.
CFR was  measured by the TTDE method in the LAD only and
the effect of WBPA on circulation in other coronary vessels was
not evaluated due to the high success rate in obtaining adequate
coronary ﬂow velocity in the LAD than in other coronary vessels
[29]. Furthermore, the TTDE method allows the measurement of
coronary ﬂow velocity without estimation of the coronary artery
diameter. However, a previous study reported a close relationship
in CFR measured by absolute coronary ﬂow and ﬂow velocity [30].
In fact, CFR derived from changes in only coronary ﬂow velocity
was used in previous large invasive studies [31,32].
Conclusions
The present study demonstrated that passive exercise using the
WBPA system improved the status of coronary microcirculation
and glucose tolerance in patients with T2D.Disclosures
There is no conﬂict of interest and ﬁnancial disclosure in our
manuscript for all the authors.
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